Albiruni Razak

16PUBLICATIONS

185CO-AUTHORS

Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 10, 2026

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Jun 04, 2026

Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue Sarcoma.

|Mar 13, 2026

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies.

Albiruni Razak, Amit Mahipal, Jennifer R Diamond

|May 23, 2025

Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.

Michael C Heinrich, Jean-Yves Blay, Hans Gelderblom

|May 12, 2025

First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak

|Dec 20, 2024

Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and Progress.

Andres Wiernik, Alvaro Rogado, Deirdre O'Mahony

Pageof 3

Frequent Collaborators

Aaron R Hansen

Philippe L Bedard

Jean-Yves Blay

Robin L Jones

Patrick Schöffski

Margaret von Mehren

Javier Martin-Broto

Axel Le Cesne

Rodrigo Ruiz-Soto

Andrew J Wagner

Frequent Collaborators

Aaron R Hansen

Philippe L Bedard

Jean-Yves Blay

Robin L Jones